Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 247

4.

Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction.

He Z, Zhang W, Chen G, Xu R, Yu XF.

J Mol Biol. 2008 Sep 12;381(4):1000-11. doi: 10.1016/j.jmb.2008.06.061.

PMID:
18619467
5.

A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion.

Xu H, Svarovskaia ES, Barr R, Zhang Y, Khan MA, Strebel K, Pathak VK.

Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5652-7.

6.

Human immunodeficiency virus type 1 Vif inhibits packaging and antiviral activity of a degradation-resistant APOBEC3G variant.

Opi S, Kao S, Goila-Gaur R, Khan MA, Miyagi E, Takeuchi H, Strebel K.

J Virol. 2007 Aug;81(15):8236-46.

10.

Regulation of APOBEC3 proteins by a novel YXXL motif in human immunodeficiency virus type 1 Vif and simian immunodeficiency virus SIVagm Vif.

Pery E, Rajendran KS, Brazier AJ, Gabuzda D.

J Virol. 2009 Mar;83(5):2374-81. doi: 10.1128/JVI.01898-08.

11.

HIV-1 Vif inhibits G to A hypermutations catalyzed by virus-encapsidated APOBEC3G to maintain HIV-1 infectivity.

Wang Y, Kinlock BL, Shao Q, Turner TM, Liu B.

Retrovirology. 2014 Oct 11;11:89. doi: 10.1186/s12977-014-0089-5.

12.

New insights into the role of Vif in HIV-1 replication.

Schröfelbauer B, Yu Q, Landau NR.

AIDS Rev. 2004 Jan-Mar;6(1):34-9. Review.

PMID:
15168739
13.
14.

Multifaceted counter-APOBEC3G mechanisms employed by HIV-1 Vif.

Britan-Rosich E, Nowarski R, Kotler M.

J Mol Biol. 2011 Jul 29;410(5):1065-76. doi: 10.1016/j.jmb.2011.03.058.

15.

APOBEC3G targets human T-cell leukemia virus type 1.

Sasada A, Takaori-Kondo A, Shirakawa K, Kobayashi M, Abudu A, Hishizawa M, Imada K, Tanaka Y, Uchiyama T.

Retrovirology. 2005 May 19;2:32.

16.

A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif).

Schröfelbauer B, Chen D, Landau NR.

Proc Natl Acad Sci U S A. 2004 Mar 16;101(11):3927-32.

17.

The anti-HIV-1 editing enzyme APOBEC3G binds HIV-1 RNA and messenger RNAs that shuttle between polysomes and stress granules.

Kozak SL, Marin M, Rose KM, Bystrom C, Kabat D.

J Biol Chem. 2006 Sep 29;281(39):29105-19.

18.

Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif.

Mariani R, Chen D, Schröfelbauer B, Navarro F, König R, Bollman B, Münk C, Nymark-McMahon H, Landau NR.

Cell. 2003 Jul 11;114(1):21-31.

19.

Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity.

Newman EN, Holmes RK, Craig HM, Klein KC, Lingappa JR, Malim MH, Sheehy AM.

Curr Biol. 2005 Jan 26;15(2):166-70.

20.

Distinct domains within APOBEC3G and APOBEC3F interact with separate regions of human immunodeficiency virus type 1 Vif.

Russell RA, Smith J, Barr R, Bhattacharyya D, Pathak VK.

J Virol. 2009 Feb;83(4):1992-2003. doi: 10.1128/JVI.01621-08.

Items per page

Supplemental Content

Support Center